id	keyword
admet-2956	pembrolizumab
admet-2956	cancer
admet-2956	cell
admet-2956	lung
admet-2956	non
admet-2956	patients
admet-2956	analysis
admet-2956	immune
admet-2956	treatment
admet-2956	cell lung
admet-2956	lung cancer
admet-2956	chemotherapy
admet-2956	expression
admet-2956	survival
admet-2956	immunotherapy